Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziltivekimab in Anemia of Inflammation in Hemodialysis
NCT02868229Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2016
- Primary completion
- Dec 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ziltivekimab in anemia, sponsored by Novo Nordisk. Started Sep 2016; status: completed.
02
Drugs
ziltivekimab
03
Conditions
anemia
Beyond the preview
Go deeper on NCT02868229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868229.